ACTRN12618000922279尚未招募2 期
Tocilizumab treatment for induction of remission in patients with idiopathic retroperitoneal fibrosis (TOCIRET)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Tocilizumab treatment with reducing and stopping methotrexate in patients with rheumatoid arthritis in stable low disease activity-stateRheumatoid arthritisJPRN-UMIN000021247agoya University Hospital53
已完成
不适用
Clinical trial of efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHDThe patients with systemic sclerosis or sclerodermatous chronic GVHD.JPRN-UMIN000020389Kanazawa University Hospital, Department of dermatology5
已完成
2 期
Effect of TOCILIZUMAB (ACTEMRA) on treatment of COVID-19COVID-19 disease.COVID-19, virus not identifiedU07.2IRCT20081027001411N4Tehran University of Medical Sciences40
已完成
不适用
Tocilizumab long-term extension trial in patients with adult onset stillAdult onset still diseaseJPRN-UMIN000018414Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine34
已完成
不适用
Tocilizumab treatment of cyclophosphamide-resistant patients with ANCA-associated vasculitisANCA-associated vasculitisJPRN-UMIN000002892Research Committee of multicentre clinical trials for intractable ANCA-associated vasculitis of the Ministry of Health, Labor and Welfare of Japan5